A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

被引：0
|
作者：
Mark E Robson
Pierre O Chappuis
Jaya Satagopan
Nora Wong
Jeff Boyd
John R Goffin
Clifford Hudis
David Roberge
Larry Norton
Louis R Bégin
Kenneth Offit
William D Foulkes
机构：
[1] Memorial Sloan-Kettering Cancer Center,Department of Medicine
[2] Cancer Prevention Centre,Research Institute of McGill University Health Centre
[3] McGill University,Department of Epidemiology/Biostatistics
[4] Memorial Sloan-Kettering Cancer Center,Cancer Prevention Centre, Sir Mortimer B Davis
[5] McGill University,Jewish General Hospital
[6] Memorial Sloan-Kettering Cancer Center,Department of Surgery
[7] McGill University,Department of Oncology
[8] McGill University,Department of Pathology
[9] McGill University,Program in Cancer Genetics, Departments of Oncology and Human Genetics
[10] University Hospitals of Geneva,Divisions of Oncology and Medical Genetics
[11] Hôpital du Sacré-Coeur de Montréal,Division of Hematology/Oncology, Department of Medicine
[12] Tufts University,undefined
[13] Tufts University-New England Medical Center,undefined
来源：
Breast Cancer Research | / 6卷
关键词：
adjuvant therapy; breast cancer; contralateral; ipsilateral; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status
    Jane C. Figueiredo
    Jennifer D. Brooks
    David V. Conti
    Jenny N. Poynter
    Sharon N. Teraoka
    Kathleen E. Malone
    Leslie Bernstein
    Won D. Lee
    David J. Duggan
    Ashley Siniard
    Patrick Concannon
    Marinela Capanu
    Charles F. Lynch
    Jørgen H. Olsen
    Robert W. Haile
    Jonine L. Bernstein
    Breast Cancer Research and Treatment, 2011, 127 : 819 - 829
  • [22] Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status
    Figueiredo, Jane C.
    Brooks, Jennifer D.
    Conti, David V.
    Poynter, Jenny N.
    Teraoka, Sharon N.
    Malone, Kathleen E.
    Bernstein, Leslie
    Lee, Won D.
    Duggan, David J.
    Siniard, Ashley
    Concannon, Patrick
    Capanu, Marinela
    Lynch, Charles F.
    Olsen, Jorgen H.
    Haile, Robert W.
    Bernstein, Jonine L.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (03) : 819 - 829
  • [23] BRCA1 and BRCA2 mutation screening in sporadic and familial breast cancer
    Ellis, D
    McCall, SH
    Greenman, J
    Evans, G
    Abbs, S
    Hodgson, SV
    Mathew, CG
    JOURNAL OF MEDICAL GENETICS, 1999, 36 : S38 - S38
  • [24] Aspirin and breast cancer risk for BRCA1 and BRCA2 mutation carriers
    Kornhauser, Naomi
    Terry, Mary Beth
    Vahdat, Linda T.
    Andrulis, Irene
    Buys, Saundra
    Daly, Mary
    John, Esther
    Hopper, John L.
    Cigler, Tessa
    CANCER RESEARCH, 2015, 75
  • [25] BRCA1 and BRCA2 mutation screening in breast cancer families.
    Phelan, CM
    Lancaster, JM
    Gumbs, C
    de los Rios, P
    Abrahamson, J
    Warner, E
    Parfrey, NA
    Futreal, PA
    Narod, SA
    BRITISH JOURNAL OF CANCER, 1998, 78 : 12 - 12
  • [26] Compliance With Tamoxifen in Women With Breast Cancer and a BRCA1 or BRCA2 Mutation
    Narod, Steven A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (33) : E698 - E699
  • [27] Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    K Metcalfe
    S Gershman
    H T Lynch
    P Ghadirian
    N Tung
    C Kim-Sing
    O I Olopade
    S Domchek
    J McLennan
    A Eisen
    W D Foulkes
    B Rosen
    P Sun
    S A Narod
    British Journal of Cancer, 2011, 104 : 1384 - 1392
  • [28] Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Joanne Kotsopoulos
    Jan Lubinski
    Leonardo Salmena
    Henry T Lynch
    Charmaine Kim-Sing
    William D Foulkes
    Parviz Ghadirian
    Susan L Neuhausen
    Rochelle Demsky
    Nadine Tung
    Peter Ainsworth
    Leigha Senter
    Andrea Eisen
    Charis Eng
    Christian Singer
    Ophira Ginsburg
    Joanne Blum
    Tomasz Huzarski
    Aletta Poll
    Ping Sun
    Steven A Narod
    Breast Cancer Research, 14
  • [29] Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    M Ahmed
    F Lalloo
    A Howell
    DG Evans
    Breast Cancer Research, 12
  • [30] Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Timothy R Rebbeck
    Susan M Domchek
    Breast Cancer Research, 10
12345